Skip to main content

Breadcrumb

  1. Home

Transdifferentiation of Multiple Myeloma into Histiocytic Sarcoma: Case Report of a Highly Unusual Phenomenon

Submitted by dana.wresch@ne… on Tue, 11/25/2025 - 09:17
  • Read more about Transdifferentiation of Multiple Myeloma into Histiocytic Sarcoma: Case Report of a Highly Unusual Phenomenon

Ring Chromosomes in Patients with Myeloid Neoplasms Are Associated with a Poor Response to Therapy

Submitted by dana.wresch@ne… on Tue, 11/25/2025 - 09:15
  • Read more about Ring Chromosomes in Patients with Myeloid Neoplasms Are Associated with a Poor Response to Therapy

Association between p16-INK4A expression and a treatment response to CDK4/6 inhibitor in advanced breast carcinoma

Submitted by dana.wresch@ne… on Tue, 11/25/2025 - 09:09
  • Read more about Association between p16-INK4A expression and a treatment response to CDK4/6 inhibitor in advanced breast carcinoma

High-grade glioma with pleomorphic and pseudopapillary features: a single-institution series of three cases

Submitted by dana.wresch@ne… on Tue, 11/25/2025 - 09:07
  • Read more about High-grade glioma with pleomorphic and pseudopapillary features: a single-institution series of three cases

Clonal hematopoiesis and inflammation predict hematologic toxicity and secondary myeloid malignancies after BCMA-directed chimeric antigen receptor T cell therapy

Submitted by dana.wresch@ne… on Tue, 11/25/2025 - 09:05
  • Read more about Clonal hematopoiesis and inflammation predict hematologic toxicity and secondary myeloid malignancies after BCMA-directed chimeric antigen receptor T cell therapy

Safety and Efficacy of Tarlatamab in patients with Neuroendocrine Prostate Cancer: Results from the Phase 1b DeLLpro-300 Study

Submitted by dana.wresch@ne… on Tue, 11/25/2025 - 09:03
  • Read more about Safety and Efficacy of Tarlatamab in patients with Neuroendocrine Prostate Cancer: Results from the Phase 1b DeLLpro-300 Study

First-in-Human Phase 1/2 Study of INCAGN01876, a Glucocorticoid-Induced Tumor Necrosis Factor Receptor Agonist, in Patients with Advanced or Metastatic Solid Tumors.

Submitted by dana.wresch@ne… on Tue, 11/25/2025 - 08:16
  • Read more about First-in-Human Phase 1/2 Study of INCAGN01876, a Glucocorticoid-Induced Tumor Necrosis Factor Receptor Agonist, in Patients with Advanced or Metastatic Solid Tumors.

Microarray

Submitted by dana.wresch@ne… on Fri, 11/07/2025 - 13:32
  • Read more about Microarray

Genomic Profiles of Early-Stage Non-Small Cell Lung Cancer Patients, and Association with Pre-Treatment Blood Circulating Tumor DNA Detection and Levels

Submitted by dana.wresch@ne… on Wed, 11/05/2025 - 15:30
  • Read more about Genomic Profiles of Early-Stage Non-Small Cell Lung Cancer Patients, and Association with Pre-Treatment Blood Circulating Tumor DNA Detection and Levels

Performance Comparison of RaDaR 1.0 and RaDaR ST Assays for Circulating Tumor DNA Detection Across Solid Tumor Types

Submitted by dana.wresch@ne… on Wed, 11/05/2025 - 15:28
  • Read more about Performance Comparison of RaDaR 1.0 and RaDaR ST Assays for Circulating Tumor DNA Detection Across Solid Tumor Types

Pagination

  • First page First
  • Previous page Previous
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page Next
  • Last page Last
Subscribe to